ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,833Medicare Part D Prescriptions Filled, Including Refills

Rank: 41 out of 487

$575K Total Retail Price of All Prescriptions

Rank: 24 out of 487

268 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
61% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Idaho
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 268 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

19% of this provider’s 268 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

3% of this provider’s 6,683 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$65 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

33 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Idaho
LEVOTHYROXINE SODIUM 397 337 1 1
OMEPRAZOLE 311 273 2 2
SIMVASTATIN 282 265 3 4
HYDROCODONE-ACETAMINOPHEN 268 160 S3 4 3
POTASSIUM CHLORIDE 203 177 5 10
LISINOPRIL 197 160 6 5
FUROSEMIDE 184 157 7 7
AMLODIPINE BESYLATE 164 150 8 6
CARVEDILOL 139 123 9 32
MELOXICAM 138 111 10 26
POLYETHYLENE GLYCOL 3350 123 111 11 56
PREDNISONE 114 105 12 37
METOPROLOL TARTRATE 110 110 13 17
MORPHINE SULFATE ER 106 68 S2 14 54
NAMENDA 103 92 15 53
TRAMADOL HCL 96 62 16 19
NEXIUM 96 65 16 41
TAMSULOSIN HCL 89 70 18 25
ZOLPIDEM TARTRATE 89 44 18 14
HYDROCHLOROTHIAZIDE 89 89 18 9
ALLOPURINOL 86 71 21 29
TRAZODONE HCL 83 40 22 22
ATORVASTATIN CALCIUM 83 72 22 18
FLUTICASONE PROPIONATE 80 69 24 33
SERTRALINE HCL 80 56 24 21
METFORMIN HCL 78 64 26 8
CYMBALTA 78 26 26 34
GABAPENTIN 78 44 26 13
RANITIDINE HCL 78 62 26 39
ROPINIROLE HCL 74 61 30 60
LOSARTAN POTASSIUM 73 62 31 16
WARFARIN SODIUM 72 58 32 11
METOLAZONE 65 57 33 146
CITALOPRAM HBR 65 64 33 12
PROMETHAZINE HCL 65 47 R 33 101
FENTANYL 63 54 S2 36 36
SPIRONOLACTONE 61 58 37 43
METOPROLOL SUCCINATE 60 54 38 15
TRIAMCINOLONE ACETONIDE 58 42 39 81
LOSARTAN-HYDROCHLOROTHIAZIDE 57 57 40 52
DONEPEZIL HCL 56 50 41 38
ABILIFY 56 0 41 128
RISPERIDONE 53 47 43 58
ATENOLOL 52 30 44 23
QUETIAPINE FUMARATE 51 37 45 69
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 9, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.